Kit for diagnosing malignant melanoma

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9465030
APP PUB NO 20150198598A1
SERIAL NO

14408883

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided is a kit for diagnosing at a high reproducibility, said kit being produced by preparing a monoclonal antibody against GPC3 and a monoclonal antibody against SPARC that are superior in quality stability to commercially available and commonly employed antibodies, and using these antibodies.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LSIP LLC7-12 MARUNOUCHI 1-CHOME CHIYODA-KU TOKYO 100-0005
NATIONAL CANCER CENTERTOKYO 104-0045

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Nakatsura, Tetsuya Kashiwa, JP 19 59
Saito, Keigo Kashiwa, JP 11 8

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 11, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00